| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Attention Deficit Disorder with Hyperactivity | 813 | 2024 | 3658 | 62.550 |
Why?
|
| Central Nervous System Stimulants | 129 | 2024 | 1148 | 21.630 |
Why?
|
| Methylphenidate | 58 | 2024 | 473 | 9.930 |
Why?
|
| Conduct Disorder | 50 | 2022 | 241 | 7.570 |
Why?
|
| Bipolar Disorder | 155 | 2023 | 5027 | 6.670 |
Why?
|
| Schizophrenia | 201 | 2023 | 6882 | 5.640 |
Why?
|
| Psychiatric Status Rating Scales | 221 | 2023 | 6036 | 5.550 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 46 | 2017 | 422 | 5.420 |
Why?
|
| Viloxazine | 7 | 2023 | 13 | 5.210 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 54 | 2021 | 304 | 5.110 |
Why?
|
| Substance-Related Disorders | 96 | 2023 | 4257 | 4.980 |
Why?
|
| Child | 629 | 2024 | 77709 | 4.460 |
Why?
|
| Adolescent | 612 | 2024 | 85779 | 4.430 |
Why?
|
| Genetic Predisposition to Disease | 194 | 2023 | 17446 | 4.250 |
Why?
|
| Comorbidity | 251 | 2024 | 10388 | 4.120 |
Why?
|
| Delayed-Action Preparations | 37 | 2023 | 968 | 3.940 |
Why?
|
| Family Health | 56 | 2015 | 1281 | 3.920 |
Why?
|
| Receptors, Dopamine D4 | 33 | 2020 | 171 | 3.800 |
Why?
|
| Dextroamphetamine | 14 | 2016 | 129 | 3.630 |
Why?
|
| Neuropsychological Tests | 137 | 2018 | 6994 | 3.600 |
Why?
|
| Family | 95 | 2020 | 3147 | 3.560 |
Why?
|
| Genetic Linkage | 60 | 2018 | 2421 | 3.520 |
Why?
|
| Executive Function | 38 | 2022 | 1364 | 3.500 |
Why?
|
| Child Behavior Disorders | 52 | 2022 | 807 | 3.390 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 81 | 2024 | 1953 | 3.260 |
Why?
|
| Siblings | 60 | 2020 | 854 | 3.200 |
Why?
|
| Amphetamines | 14 | 2021 | 148 | 3.130 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 21 | 2017 | 322 | 3.040 |
Why?
|
| Amphetamine | 12 | 2024 | 225 | 2.930 |
Why?
|
| Humans | 1235 | 2024 | 744366 | 2.810 |
Why?
|
| Genome-Wide Association Study | 85 | 2023 | 12262 | 2.620 |
Why?
|
| Male | 835 | 2023 | 350115 | 2.560 |
Why?
|
| Intelligence | 38 | 2020 | 920 | 2.560 |
Why?
|
| Cognition Disorders | 54 | 2021 | 4043 | 2.510 |
Why?
|
| Mental Disorders | 91 | 2020 | 6598 | 2.440 |
Why?
|
| Female | 789 | 2023 | 380193 | 2.380 |
Why?
|
| Schizophrenic Psychology | 65 | 2015 | 1678 | 2.360 |
Why?
|
| Aggression | 22 | 2022 | 753 | 2.200 |
Why?
|
| Polymorphism, Single Nucleotide | 110 | 2023 | 15520 | 2.190 |
Why?
|
| Polymorphism, Genetic | 42 | 2016 | 4328 | 2.170 |
Why?
|
| Adult | 493 | 2024 | 214052 | 2.160 |
Why?
|
| Depressive Disorder, Major | 46 | 2023 | 4639 | 2.140 |
Why?
|
| Case-Control Studies | 161 | 2024 | 21748 | 2.130 |
Why?
|
| Child Behavior | 23 | 2022 | 839 | 2.120 |
Why?
|
| Parents | 54 | 2022 | 3405 | 2.120 |
Why?
|
| Personality Assessment | 41 | 2010 | 647 | 2.040 |
Why?
|
| Antisocial Personality Disorder | 30 | 2022 | 228 | 2.040 |
Why?
|
| Attention | 43 | 2020 | 2397 | 2.020 |
Why?
|
| Anxiety Disorders | 79 | 2023 | 2690 | 2.010 |
Why?
|
| Catechol O-Methyltransferase | 11 | 2017 | 245 | 1.990 |
Why?
|
| Impulsive Behavior | 21 | 2021 | 316 | 1.890 |
Why?
|
| Genotype | 112 | 2023 | 12952 | 1.870 |
Why?
|
| Minisatellite Repeats | 22 | 2020 | 165 | 1.870 |
Why?
|
| Psychometrics | 59 | 2021 | 3003 | 1.840 |
Why?
|
| Child of Impaired Parents | 32 | 2012 | 455 | 1.810 |
Why?
|
| Memory, Short-Term | 26 | 2018 | 977 | 1.750 |
Why?
|
| Propylamines | 18 | 2013 | 165 | 1.670 |
Why?
|
| Affective Symptoms | 10 | 2019 | 407 | 1.660 |
Why?
|
| Genetic Markers | 42 | 2019 | 2634 | 1.640 |
Why?
|
| Adrenergic Uptake Inhibitors | 12 | 2018 | 189 | 1.640 |
Why?
|
| Double-Blind Method | 60 | 2023 | 12025 | 1.630 |
Why?
|
| Alleles | 56 | 2022 | 6933 | 1.620 |
Why?
|
| Linkage Disequilibrium | 40 | 2019 | 1997 | 1.570 |
Why?
|
| Interview, Psychological | 30 | 2016 | 812 | 1.570 |
Why?
|
| Young Adult | 163 | 2023 | 56429 | 1.560 |
Why?
|
| Age of Onset | 54 | 2019 | 3270 | 1.520 |
Why?
|
| Risk Factors | 232 | 2024 | 72296 | 1.510 |
Why?
|
| Sex Factors | 85 | 2019 | 10400 | 1.480 |
Why?
|
| Monoamine Oxidase | 7 | 2011 | 178 | 1.450 |
Why?
|
| Social Adjustment | 29 | 2018 | 631 | 1.430 |
Why?
|
| Nuclear Family | 19 | 2013 | 318 | 1.390 |
Why?
|
| Brain | 76 | 2024 | 26388 | 1.380 |
Why?
|
| Panic Disorder | 32 | 2018 | 616 | 1.380 |
Why?
|
| Dose-Response Relationship, Drug | 41 | 2023 | 10943 | 1.380 |
Why?
|
| Mood Disorders | 29 | 2022 | 1106 | 1.370 |
Why?
|
| Temperament | 15 | 2019 | 283 | 1.360 |
Why?
|
| Checklist | 13 | 2022 | 833 | 1.330 |
Why?
|
| Gene Frequency | 48 | 2017 | 3587 | 1.320 |
Why?
|
| Psychotropic Drugs | 13 | 2018 | 894 | 1.310 |
Why?
|
| Psychotic Disorders | 41 | 2020 | 3046 | 1.300 |
Why?
|
| Haplotypes | 40 | 2016 | 2779 | 1.280 |
Why?
|
| Prenatal Exposure Delayed Effects | 20 | 2020 | 2408 | 1.260 |
Why?
|
| Social Control, Informal | 3 | 2013 | 46 | 1.260 |
Why?
|
| Depressive Disorder | 53 | 2019 | 3747 | 1.250 |
Why?
|
| Schizotypal Personality Disorder | 16 | 2011 | 288 | 1.230 |
Why?
|
| Video Games | 3 | 2020 | 184 | 1.210 |
Why?
|
| Prodrugs | 3 | 2023 | 268 | 1.200 |
Why?
|
| Severity of Illness Index | 92 | 2020 | 15535 | 1.190 |
Why?
|
| Prevalence | 70 | 2024 | 15221 | 1.180 |
Why?
|
| Multifactorial Inheritance | 22 | 2023 | 1195 | 1.170 |
Why?
|
| Longitudinal Studies | 77 | 2022 | 13991 | 1.170 |
Why?
|
| Smoking | 28 | 2020 | 8987 | 1.160 |
Why?
|
| Social Environment | 26 | 2016 | 1022 | 1.150 |
Why?
|
| Phenotype | 85 | 2023 | 16367 | 1.150 |
Why?
|
| Child Psychiatry | 5 | 2024 | 220 | 1.140 |
Why?
|
| Guanfacine | 5 | 2023 | 51 | 1.140 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 6 | 2017 | 64 | 1.140 |
Why?
|
| Emotions | 10 | 2018 | 2659 | 1.100 |
Why?
|
| Age Factors | 98 | 2019 | 18373 | 1.100 |
Why?
|
| Mothers | 16 | 2022 | 2165 | 1.080 |
Why?
|
| Adolescent Psychiatry | 4 | 2024 | 148 | 1.070 |
Why?
|
| Follow-Up Studies | 108 | 2022 | 39052 | 1.060 |
Why?
|
| Child, Preschool | 122 | 2024 | 41005 | 1.050 |
Why?
|
| Rats, Inbred SHR | 10 | 2014 | 195 | 1.040 |
Why?
|
| Twin Studies as Topic | 13 | 2011 | 105 | 1.030 |
Why?
|
| Anxiety | 21 | 2023 | 4293 | 1.020 |
Why?
|
| Psychopathology | 13 | 2023 | 409 | 1.020 |
Why?
|
| Child Development Disorders, Pervasive | 9 | 2016 | 615 | 1.020 |
Why?
|
| DiGeorge Syndrome | 10 | 2018 | 177 | 1.020 |
Why?
|
| Tobacco Use Disorder | 9 | 2019 | 688 | 1.010 |
Why?
|
| Receptors, Dopamine D2 | 13 | 2015 | 475 | 1.000 |
Why?
|
| Cognition | 33 | 2023 | 6770 | 1.000 |
Why?
|
| Quality of Life | 20 | 2024 | 12802 | 0.990 |
Why?
|
| Genetic Association Studies | 24 | 2017 | 2703 | 0.980 |
Why?
|
| Problem Solving | 10 | 2008 | 440 | 0.970 |
Why?
|
| Reward | 12 | 2023 | 940 | 0.970 |
Why?
|
| Pregnancy Complications | 13 | 2016 | 2861 | 0.970 |
Why?
|
| Sweden | 12 | 2022 | 1341 | 0.950 |
Why?
|
| Genetic Heterogeneity | 9 | 2017 | 733 | 0.950 |
Why?
|
| Reproducibility of Results | 69 | 2021 | 19905 | 0.930 |
Why?
|
| Self Report | 20 | 2023 | 3553 | 0.930 |
Why?
|
| Treatment Outcome | 82 | 2024 | 63107 | 0.930 |
Why?
|
| Stress Disorders, Post-Traumatic | 12 | 2021 | 4266 | 0.920 |
Why?
|
| Quantitative Trait Loci | 11 | 2019 | 2019 | 0.910 |
Why?
|
| Alcoholism | 14 | 2021 | 1906 | 0.910 |
Why?
|
| Intelligence Tests | 15 | 2020 | 505 | 0.900 |
Why?
|
| Dopamine Uptake Inhibitors | 7 | 2018 | 312 | 0.900 |
Why?
|
| Diseases in Twins | 20 | 2010 | 449 | 0.890 |
Why?
|
| Affective Disorders, Psychotic | 5 | 2016 | 191 | 0.880 |
Why?
|
| Drug Administration Schedule | 24 | 2021 | 4933 | 0.870 |
Why?
|
| Middle Aged | 228 | 2023 | 213390 | 0.860 |
Why?
|
| Genome, Human | 25 | 2020 | 4420 | 0.860 |
Why?
|
| Body Height | 8 | 2011 | 1578 | 0.840 |
Why?
|
| Environment | 10 | 2017 | 1123 | 0.810 |
Why?
|
| Obsessive-Compulsive Disorder | 17 | 2021 | 1444 | 0.800 |
Why?
|
| Serotonin | 6 | 2020 | 1017 | 0.790 |
Why?
|
| Randomized Controlled Trials as Topic | 21 | 2023 | 9955 | 0.780 |
Why?
|
| Body Weight | 11 | 2021 | 4671 | 0.780 |
Why?
|
| Placebos | 15 | 2012 | 1676 | 0.780 |
Why?
|
| Genomics | 14 | 2024 | 5717 | 0.780 |
Why?
|
| Adoption | 12 | 2008 | 97 | 0.760 |
Why?
|
| Receptors, Dopamine D5 | 7 | 2016 | 32 | 0.760 |
Why?
|
| Registries | 14 | 2023 | 8091 | 0.750 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 6 | 2017 | 66 | 0.750 |
Why?
|
| Endophenotypes | 4 | 2018 | 250 | 0.750 |
Why?
|
| Models, Genetic | 27 | 2013 | 3493 | 0.740 |
Why?
|
| Psychomotor Performance | 18 | 2017 | 1901 | 0.740 |
Why?
|
| Educational Status | 19 | 2022 | 2540 | 0.730 |
Why?
|
| Personality Inventory | 12 | 2015 | 1030 | 0.720 |
Why?
|
| Europe | 27 | 2024 | 3338 | 0.720 |
Why?
|
| Schools | 9 | 2021 | 1433 | 0.720 |
Why?
|
| Rats, Inbred WKY | 8 | 2014 | 158 | 0.720 |
Why?
|
| Activities of Daily Living | 8 | 2019 | 2419 | 0.710 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 5 | 2009 | 33 | 0.700 |
Why?
|
| Automobile Driver Examination | 1 | 2019 | 24 | 0.700 |
Why?
|
| Molecular Biology | 6 | 2010 | 596 | 0.700 |
Why?
|
| Wechsler Scales | 19 | 2016 | 260 | 0.700 |
Why?
|
| Risk | 36 | 2018 | 9688 | 0.690 |
Why?
|
| Magnetic Resonance Imaging | 73 | 2023 | 35425 | 0.690 |
Why?
|
| Chromosome Mapping | 26 | 2012 | 4740 | 0.690 |
Why?
|
| Prescriptions | 4 | 2022 | 387 | 0.680 |
Why?
|
| Gender Identity | 2 | 2023 | 687 | 0.680 |
Why?
|
| Antipsychotic Agents | 23 | 2022 | 3057 | 0.680 |
Why?
|
| Memory Disorders | 11 | 2016 | 1186 | 0.680 |
Why?
|
| Sex Characteristics | 18 | 2021 | 2585 | 0.680 |
Why?
|
| Cerebral Cortex | 14 | 2021 | 5709 | 0.680 |
Why?
|
| Gene Expression | 16 | 2021 | 7798 | 0.670 |
Why?
|
| Memantine | 2 | 2016 | 100 | 0.660 |
Why?
|
| Reaction Time | 20 | 2021 | 2098 | 0.660 |
Why?
|
| Receptors, Serotonin | 4 | 2007 | 201 | 0.650 |
Why?
|
| Achievement | 14 | 2023 | 291 | 0.650 |
Why?
|
| Cross-Over Studies | 14 | 2021 | 2029 | 0.650 |
Why?
|
| Tic Disorders | 6 | 2024 | 127 | 0.650 |
Why?
|
| Tourette Syndrome | 9 | 2021 | 379 | 0.640 |
Why?
|
| Autistic Disorder | 7 | 2015 | 1185 | 0.630 |
Why?
|
| Referral and Consultation | 22 | 2020 | 3531 | 0.630 |
Why?
|
| Self-Assessment | 6 | 2013 | 390 | 0.630 |
Why?
|
| China | 18 | 2021 | 2245 | 0.620 |
Why?
|
| Personality | 5 | 2020 | 552 | 0.620 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 3 | 2006 | 63 | 0.610 |
Why?
|
| ROC Curve | 12 | 2020 | 3528 | 0.610 |
Why?
|
| Mother-Child Relations | 6 | 2016 | 481 | 0.600 |
Why?
|
| Pedigree | 33 | 2013 | 4642 | 0.600 |
Why?
|
| Neurosecretory Systems | 2 | 2020 | 231 | 0.600 |
Why?
|
| Desipramine | 9 | 2002 | 184 | 0.600 |
Why?
|
| Medication Adherence | 7 | 2020 | 2063 | 0.600 |
Why?
|
| Birth Weight | 4 | 2015 | 2069 | 0.590 |
Why?
|
| Antidepressive Agents | 12 | 2022 | 2838 | 0.590 |
Why?
|
| Growth Disorders | 3 | 2011 | 645 | 0.580 |
Why?
|
| Obstetric Labor Complications | 7 | 2014 | 238 | 0.570 |
Why?
|
| Eye Diseases | 1 | 2022 | 669 | 0.570 |
Why?
|
| Fetal Movement | 1 | 2016 | 21 | 0.570 |
Why?
|
| Lod Score | 17 | 2010 | 614 | 0.570 |
Why?
|
| Chromosomes, Human, Pair 9 | 6 | 2013 | 535 | 0.560 |
Why?
|
| Adolescent Behavior | 12 | 2017 | 1151 | 0.550 |
Why?
|
| Emotional Intelligence | 3 | 2012 | 136 | 0.550 |
Why?
|
| Receptors, Nicotinic | 5 | 2012 | 497 | 0.550 |
Why?
|
| Cross-Sectional Studies | 45 | 2022 | 25039 | 0.540 |
Why?
|
| Genetic Variation | 26 | 2018 | 6542 | 0.540 |
Why?
|
| Sex Ratio | 3 | 2013 | 110 | 0.540 |
Why?
|
| Disease Models, Animal | 13 | 2014 | 18034 | 0.530 |
Why?
|
| Chi-Square Distribution | 24 | 2016 | 3508 | 0.530 |
Why?
|
| Genome | 6 | 2013 | 1807 | 0.530 |
Why?
|
| Dopamine | 7 | 2020 | 1591 | 0.530 |
Why?
|
| Brain Mapping | 32 | 2019 | 6670 | 0.530 |
Why?
|
| Fetal Weight | 1 | 2015 | 80 | 0.520 |
Why?
|
| Primary Health Care | 7 | 2024 | 4557 | 0.520 |
Why?
|
| Single-Blind Method | 6 | 2024 | 1590 | 0.520 |
Why?
|
| Factor Analysis, Statistical | 15 | 2019 | 977 | 0.520 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 2013 | 177 | 0.520 |
Why?
|
| Nicotine | 5 | 2013 | 681 | 0.510 |
Why?
|
| Pregnancy | 43 | 2020 | 29144 | 0.510 |
Why?
|
| Receptors, Dopamine | 3 | 2008 | 295 | 0.510 |
Why?
|
| Quantitative Trait, Heritable | 4 | 2018 | 544 | 0.510 |
Why?
|
| Expressed Emotion | 5 | 2016 | 92 | 0.510 |
Why?
|
| Behavior Therapy | 2 | 2020 | 865 | 0.500 |
Why?
|
| Opioid Peptides | 1 | 2014 | 42 | 0.500 |
Why?
|
| Prospective Studies | 58 | 2022 | 53290 | 0.500 |
Why?
|
| Twins | 8 | 2012 | 339 | 0.500 |
Why?
|
| Inheritance Patterns | 4 | 2013 | 340 | 0.490 |
Why?
|
| Life Change Events | 5 | 2014 | 938 | 0.490 |
Why?
|
| Antidepressive Agents, Tricyclic | 10 | 2006 | 434 | 0.490 |
Why?
|
| Frontal Lobe | 10 | 2015 | 1406 | 0.490 |
Why?
|
| Evidence-Based Practice | 2 | 2020 | 501 | 0.490 |
Why?
|
| Growth | 2 | 2007 | 376 | 0.480 |
Why?
|
| Auditory Perception | 4 | 2016 | 569 | 0.480 |
Why?
|
| Fibromyalgia | 2 | 2018 | 388 | 0.480 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 2013 | 16 | 0.470 |
Why?
|
| Chromosomes, Human, Pair 10 | 4 | 2011 | 287 | 0.470 |
Why?
|
| Verbal Learning | 11 | 2011 | 468 | 0.470 |
Why?
|
| Membrane Transport Modulators | 1 | 2013 | 24 | 0.470 |
Why?
|
| Patient Participation | 2 | 2020 | 1457 | 0.470 |
Why?
|
| Personality Disorders | 8 | 2019 | 713 | 0.470 |
Why?
|
| Brain Injuries | 4 | 2015 | 2029 | 0.460 |
Why?
|
| Tics | 2 | 2004 | 70 | 0.460 |
Why?
|
| Behavior | 2 | 2015 | 561 | 0.460 |
Why?
|
| Income | 2 | 2017 | 1913 | 0.460 |
Why?
|
| Gyrus Cinguli | 7 | 2015 | 1091 | 0.460 |
Why?
|
| Research Design | 24 | 2020 | 5984 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 15 | 7 | 2015 | 373 | 0.460 |
Why?
|
| Bupropion | 5 | 2009 | 303 | 0.450 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2013 | 53 | 0.450 |
Why?
|
| Euphoria | 4 | 2018 | 67 | 0.450 |
Why?
|
| Membrane Glycoproteins | 12 | 2021 | 3771 | 0.450 |
Why?
|
| Brain-Derived Neurotrophic Factor | 5 | 2010 | 604 | 0.450 |
Why?
|
| Lupus Erythematosus, Systemic | 6 | 2018 | 2104 | 0.450 |
Why?
|
| Electronic Health Records | 8 | 2023 | 4468 | 0.450 |
Why?
|
| Treatment Refusal | 3 | 2007 | 421 | 0.440 |
Why?
|
| Reference Values | 21 | 2019 | 4982 | 0.440 |
Why?
|
| Pharmacogenetics | 7 | 2017 | 674 | 0.440 |
Why?
|
| Quality of Health Care | 5 | 2023 | 4369 | 0.440 |
Why?
|
| Underachievement | 3 | 2008 | 15 | 0.440 |
Why?
|
| Salts | 3 | 2024 | 65 | 0.440 |
Why?
|
| Chromosomes, Human, Pair 6 | 10 | 2010 | 380 | 0.430 |
Why?
|
| Israel | 6 | 2014 | 796 | 0.430 |
Why?
|
| Prefrontal Cortex | 19 | 2017 | 2147 | 0.430 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 1125 | 0.430 |
Why?
|
| Time Factors | 31 | 2023 | 40075 | 0.420 |
Why?
|
| Evoked Potentials | 2 | 2017 | 1056 | 0.420 |
Why?
|
| Social Class | 21 | 2014 | 1997 | 0.420 |
Why?
|
| Nerve Net | 6 | 2018 | 2175 | 0.420 |
Why?
|
| Odds Ratio | 37 | 2020 | 9849 | 0.420 |
Why?
|
| Goals | 2 | 2019 | 707 | 0.420 |
Why?
|
| Chlorodiphenyl (54% Chlorine) | 1 | 2011 | 2 | 0.420 |
Why?
|
| Aroclors | 1 | 2011 | 3 | 0.420 |
Why?
|
| Diagnosis, Differential | 29 | 2015 | 12961 | 0.410 |
Why?
|
| Caregivers | 3 | 2021 | 2095 | 0.410 |
Why?
|
| Chromosomes, Human, Pair 13 | 5 | 2012 | 197 | 0.410 |
Why?
|
| Psychomotor Disorders | 4 | 2015 | 152 | 0.410 |
Why?
|
| Nerve Tissue Proteins | 13 | 2022 | 4463 | 0.410 |
Why?
|
| Hippocampus | 10 | 2019 | 3675 | 0.410 |
Why?
|
| Naltrexone | 3 | 2018 | 307 | 0.400 |
Why?
|
| Asthma | 7 | 2018 | 6010 | 0.400 |
Why?
|
| Stress, Psychological | 6 | 2017 | 4245 | 0.400 |
Why?
|
| Regression Analysis | 24 | 2019 | 6459 | 0.400 |
Why?
|
| Drug Repositioning | 1 | 2013 | 230 | 0.390 |
Why?
|
| Models, Biological | 5 | 2020 | 9584 | 0.390 |
Why?
|
| Models, Psychological | 6 | 2011 | 811 | 0.390 |
Why?
|
| Pilot Projects | 26 | 2022 | 8319 | 0.390 |
Why?
|
| Species Specificity | 7 | 2014 | 2478 | 0.390 |
Why?
|
| Body Mass Index | 12 | 2023 | 12721 | 0.390 |
Why?
|
| Employment | 6 | 2015 | 1132 | 0.390 |
Why?
|
| Antidepressive Agents, Second-Generation | 2 | 2021 | 503 | 0.380 |
Why?
|
| Stress, Physiological | 2 | 2018 | 1403 | 0.380 |
Why?
|
| Gestational Age | 2 | 2017 | 3493 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 22 | 7 | 2017 | 351 | 0.380 |
Why?
|
| Mental Recall | 6 | 2013 | 1206 | 0.380 |
Why?
|
| Affect | 3 | 2017 | 1475 | 0.380 |
Why?
|
| Taiwan | 14 | 2017 | 496 | 0.370 |
Why?
|
| National Institute of Mental Health (U.S.) | 6 | 2020 | 107 | 0.370 |
Why?
|
| Interviews as Topic | 10 | 2014 | 2539 | 0.370 |
Why?
|
| Obesity | 7 | 2018 | 12746 | 0.370 |
Why?
|
| Tryptophan Hydroxylase | 3 | 2008 | 89 | 0.370 |
Why?
|
| Analysis of Variance | 24 | 2013 | 6366 | 0.370 |
Why?
|
| Logistic Models | 30 | 2019 | 13409 | 0.360 |
Why?
|
| Suicide | 2 | 2020 | 1474 | 0.360 |
Why?
|
| Organ Size | 10 | 2020 | 2251 | 0.360 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 2 | 2006 | 44 | 0.360 |
Why?
|
| Overweight | 5 | 2017 | 2371 | 0.360 |
Why?
|
| Choice Behavior | 5 | 2011 | 802 | 0.360 |
Why?
|
| Students | 2 | 2019 | 1647 | 0.350 |
Why?
|
| Risperidone | 4 | 2022 | 383 | 0.350 |
Why?
|
| Synaptosomal-Associated Protein 25 | 7 | 2009 | 52 | 0.350 |
Why?
|
| Mass Screening | 10 | 2021 | 5253 | 0.350 |
Why?
|
| Apolipoprotein E4 | 3 | 2022 | 668 | 0.340 |
Why?
|
| Antimanic Agents | 6 | 2022 | 522 | 0.340 |
Why?
|
| Probability | 14 | 2022 | 2506 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2010 | 658 | 0.340 |
Why?
|
| Parent-Child Relations | 6 | 2008 | 747 | 0.340 |
Why?
|
| Family Relations | 6 | 2011 | 321 | 0.340 |
Why?
|
| Faculty | 3 | 2011 | 387 | 0.340 |
Why?
|
| Clinical Trials as Topic | 11 | 2022 | 7914 | 0.330 |
Why?
|
| Agoraphobia | 14 | 2012 | 179 | 0.330 |
Why?
|
| Individuality | 1 | 2010 | 307 | 0.330 |
Why?
|
| DNA Copy Number Variations | 8 | 2018 | 1941 | 0.330 |
Why?
|
| Rats | 13 | 2018 | 24252 | 0.330 |
Why?
|
| D-Amino-Acid Oxidase | 3 | 2016 | 27 | 0.320 |
Why?
|
| Gene Expression Profiling | 9 | 2023 | 9445 | 0.320 |
Why?
|
| Drug Compounding | 2 | 2021 | 242 | 0.320 |
Why?
|
| Acoustic Stimulation | 2 | 2012 | 1216 | 0.320 |
Why?
|
| Administration, Cutaneous | 4 | 2015 | 711 | 0.320 |
Why?
|
| Phobic Disorders | 9 | 2012 | 439 | 0.320 |
Why?
|
| Massachusetts | 18 | 2019 | 8662 | 0.320 |
Why?
|
| Quality Indicators, Health Care | 1 | 2018 | 1831 | 0.320 |
Why?
|
| Meta-Analysis as Topic | 7 | 2019 | 1342 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 16 | 3 | 2010 | 354 | 0.310 |
Why?
|
| Membrane Transport Proteins | 8 | 2005 | 1031 | 0.310 |
Why?
|
| Demography | 12 | 2013 | 1655 | 0.310 |
Why?
|
| Chromosomes, Human | 4 | 2011 | 457 | 0.310 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2008 | 178 | 0.310 |
Why?
|
| Gene Dosage | 2 | 2012 | 1252 | 0.310 |
Why?
|
| Athletes | 1 | 2015 | 1093 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2008 | 323 | 0.310 |
Why?
|
| Maternal Behavior | 5 | 2016 | 311 | 0.310 |
Why?
|
| Palau | 5 | 2014 | 5 | 0.310 |
Why?
|
| Predictive Value of Tests | 20 | 2020 | 15078 | 0.310 |
Why?
|
| Aging | 8 | 2018 | 8664 | 0.300 |
Why?
|
| Drug Prescriptions | 5 | 2024 | 1637 | 0.300 |
Why?
|
| Terminology as Topic | 7 | 2002 | 1547 | 0.300 |
Why?
|
| Receptor, Serotonin, 5-HT1D | 1 | 2006 | 9 | 0.300 |
Why?
|
| Family Characteristics | 9 | 2013 | 1000 | 0.300 |
Why?
|
| Adolescent Development | 3 | 2015 | 279 | 0.300 |
Why?
|
| Sibling Relations | 5 | 2008 | 45 | 0.300 |
Why?
|
| Mental Processes | 2 | 2007 | 249 | 0.290 |
Why?
|
| Epistasis, Genetic | 1 | 2009 | 365 | 0.290 |
Why?
|
| Socioeconomic Factors | 24 | 2016 | 7785 | 0.290 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 9 | 2016 | 3921 | 0.290 |
Why?
|
| Self Disclosure | 2 | 2009 | 251 | 0.290 |
Why?
|
| France | 3 | 2015 | 517 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2005 | 299 | 0.290 |
Why?
|
| Tandem Repeat Sequences | 4 | 2007 | 185 | 0.290 |
Why?
|
| Health Status | 5 | 2017 | 4034 | 0.290 |
Why?
|
| Introns | 9 | 2009 | 992 | 0.290 |
Why?
|
| Social Behavior Disorders | 5 | 2016 | 97 | 0.290 |
Why?
|
| Cohort Studies | 33 | 2022 | 40559 | 0.280 |
Why?
|
| Discrimination Learning | 5 | 2007 | 280 | 0.280 |
Why?
|
| Functional Laterality | 13 | 2017 | 2290 | 0.280 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2008 | 245 | 0.280 |
Why?
|
| Receptors, Serotonin, 5-HT4 | 1 | 2006 | 16 | 0.280 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2008 | 456 | 0.280 |
Why?
|
| Psychological Tests | 10 | 2013 | 651 | 0.280 |
Why?
|
| Temporal Lobe | 6 | 2015 | 1670 | 0.280 |
Why?
|
| Lithium | 3 | 2016 | 601 | 0.280 |
Why?
|
| Dizziness | 1 | 2009 | 251 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2010 | 245 | 0.280 |
Why?
|
| Osmosis | 3 | 2016 | 113 | 0.280 |
Why?
|
| Family Conflict | 3 | 2018 | 95 | 0.280 |
Why?
|
| Computer Simulation | 7 | 2013 | 6194 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 8 | 5 | 2010 | 460 | 0.270 |
Why?
|
| Endothelins | 5 | 1997 | 138 | 0.270 |
Why?
|
| Nausea | 1 | 2009 | 674 | 0.270 |
Why?
|
| Alzheimer Disease | 5 | 2022 | 8038 | 0.270 |
Why?
|
| Databases, Genetic | 5 | 2020 | 1783 | 0.270 |
Why?
|
| Cerebellum | 8 | 2017 | 1488 | 0.270 |
Why?
|
| Genetics | 2 | 2011 | 112 | 0.270 |
Why?
|
| Antioxidants | 1 | 2013 | 1659 | 0.260 |
Why?
|
| Software | 1 | 2020 | 4441 | 0.260 |
Why?
|
| Motivation | 7 | 2019 | 1971 | 0.260 |
Why?
|
| Athletic Injuries | 1 | 2015 | 1154 | 0.260 |
Why?
|
| Irritable Mood | 5 | 2019 | 183 | 0.260 |
Why?
|
| Fathers | 6 | 2021 | 358 | 0.260 |
Why?
|
| Pattern Recognition, Visual | 4 | 2015 | 824 | 0.260 |
Why?
|
| Psychiatry | 7 | 2024 | 1695 | 0.260 |
Why?
|
| Mental Status Schedule | 3 | 2014 | 321 | 0.260 |
Why?
|
| Oxidative Stress | 2 | 2013 | 3084 | 0.260 |
Why?
|
| Catecholamines | 2 | 2006 | 387 | 0.260 |
Why?
|
| Observer Variation | 10 | 2011 | 2593 | 0.260 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 5 | 2013 | 295 | 0.260 |
Why?
|
| Cluster Analysis | 7 | 2013 | 2715 | 0.260 |
Why?
|
| Suicide, Attempted | 3 | 2020 | 1218 | 0.250 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2011 | 816 | 0.250 |
Why?
|
| Sensitivity and Specificity | 19 | 2017 | 14723 | 0.250 |
Why?
|
| World Health Organization | 2 | 2024 | 1318 | 0.250 |
Why?
|
| Acetylcysteine | 3 | 2022 | 271 | 0.250 |
Why?
|
| Automobile Driving | 4 | 2012 | 431 | 0.240 |
Why?
|
| Mutation | 6 | 2022 | 29786 | 0.240 |
Why?
|
| Cause of Death | 1 | 2015 | 3582 | 0.240 |
Why?
|
| Psychophysiologic Disorders | 1 | 2006 | 228 | 0.240 |
Why?
|
| Linear Models | 15 | 2017 | 5953 | 0.240 |
Why?
|
| Principal Component Analysis | 6 | 2021 | 940 | 0.240 |
Why?
|
| Animals | 34 | 2022 | 168768 | 0.230 |
Why?
|
| Genetics, Medical | 2 | 2006 | 338 | 0.230 |
Why?
|
| Algorithms | 11 | 2023 | 13882 | 0.230 |
Why?
|
| Depression | 12 | 2018 | 7759 | 0.230 |
Why?
|
| Netherlands | 10 | 2023 | 2170 | 0.230 |
Why?
|
| Familial Mediterranean Fever | 1 | 2023 | 61 | 0.230 |
Why?
|
| Patient Compliance | 3 | 2019 | 2684 | 0.230 |
Why?
|
| Publication Bias | 2 | 2021 | 162 | 0.230 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2023 | 89 | 0.230 |
Why?
|
| Suspensions | 1 | 2023 | 65 | 0.230 |
Why?
|
| Anxiety, Separation | 7 | 2007 | 86 | 0.220 |
Why?
|
| Social Behavior | 10 | 2014 | 1127 | 0.220 |
Why?
|
| Personality Tests | 2 | 2022 | 83 | 0.220 |
Why?
|
| Caudate Nucleus | 4 | 2021 | 393 | 0.220 |
Why?
|
| Aged | 61 | 2023 | 163288 | 0.220 |
Why?
|
| Peer Group | 4 | 2016 | 635 | 0.220 |
Why?
|
| Heroin Dependence | 4 | 2008 | 175 | 0.220 |
Why?
|
| Human Development | 2 | 2021 | 124 | 0.220 |
Why?
|
| Telemedicine | 1 | 2020 | 2872 | 0.220 |
Why?
|
| Character | 2 | 2015 | 26 | 0.220 |
Why?
|
| Disease Susceptibility | 7 | 2019 | 1782 | 0.220 |
Why?
|
| Judgment | 1 | 2005 | 281 | 0.210 |
Why?
|
| Child Development | 7 | 2015 | 2223 | 0.210 |
Why?
|
| Arousal | 5 | 2018 | 1164 | 0.210 |
Why?
|
| Neuropharmacology | 1 | 2022 | 21 | 0.210 |
Why?
|
| Synaptophysin | 2 | 2013 | 141 | 0.210 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 8642 | 0.210 |
Why?
|
| Nerve Fibers, Unmyelinated | 2 | 2013 | 98 | 0.210 |
Why?
|
| Sirolimus | 3 | 2018 | 1565 | 0.210 |
Why?
|
| DNA | 13 | 2011 | 7294 | 0.200 |
Why?
|
| Population Surveillance | 2 | 2019 | 2616 | 0.200 |
Why?
|
| Dyslexia | 5 | 2012 | 248 | 0.200 |
Why?
|
| Hyperkinesis | 3 | 2013 | 89 | 0.200 |
Why?
|
| Free Radical Scavengers | 2 | 2013 | 216 | 0.200 |
Why?
|
| Thalamus | 5 | 2017 | 1023 | 0.200 |
Why?
|
| Diabetes Complications | 1 | 2009 | 1359 | 0.200 |
Why?
|
| Fatigue | 1 | 2009 | 1531 | 0.200 |
Why?
|
| Forecasting | 7 | 2022 | 2951 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2014 | 8300 | 0.200 |
Why?
|
| Pregnancy in Adolescence | 2 | 2017 | 158 | 0.200 |
Why?
|
| Mathematics | 4 | 2017 | 728 | 0.200 |
Why?
|
| Electroencephalography | 1 | 2017 | 6151 | 0.200 |
Why?
|
| Multicenter Studies as Topic | 7 | 2020 | 1677 | 0.200 |
Why?
|
| Interpersonal Relations | 9 | 2016 | 1425 | 0.200 |
Why?
|
| Excitatory Amino Acid Transporter 3 | 2 | 2013 | 32 | 0.200 |
Why?
|
| Neural Pathways | 5 | 2018 | 2974 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2012 | 4554 | 0.200 |
Why?
|
| Neurobiology | 1 | 2022 | 121 | 0.190 |
Why?
|
| Benzodiazepines | 3 | 2022 | 1101 | 0.190 |
Why?
|
| Alternative Splicing | 4 | 2020 | 1117 | 0.190 |
Why?
|
| Bullying | 1 | 2024 | 210 | 0.190 |
Why?
|
| Sex Distribution | 10 | 2015 | 2297 | 0.190 |
Why?
|
| Pediatrics | 4 | 2020 | 3475 | 0.190 |
Why?
|
| United States | 44 | 2022 | 69872 | 0.190 |
Why?
|
| Proportional Hazards Models | 14 | 2020 | 12356 | 0.190 |
Why?
|
| Likelihood Functions | 5 | 2013 | 1005 | 0.190 |
Why?
|
| Opioid-Related Disorders | 2 | 2018 | 2064 | 0.190 |
Why?
|
| Recurrence | 11 | 2009 | 8340 | 0.190 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2004 | 632 | 0.190 |
Why?
|
| Human Genome Project | 3 | 2010 | 193 | 0.190 |
Why?
|
| Sex Offenses | 2 | 2024 | 354 | 0.190 |
Why?
|
| Receptors, Cell Surface | 3 | 2005 | 2865 | 0.190 |
Why?
|
| Multivariate Analysis | 13 | 2019 | 12244 | 0.190 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2024 | 245 | 0.190 |
Why?
|
| Genetics, Population | 6 | 2019 | 934 | 0.180 |
Why?
|
| Placebo Effect | 2 | 2021 | 502 | 0.180 |
Why?
|
| Exons | 5 | 2020 | 2439 | 0.180 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2015 | 2305 | 0.180 |
Why?
|
| Drug Therapy, Combination | 6 | 2018 | 6489 | 0.180 |
Why?
|
| Genetic Loci | 5 | 2018 | 2575 | 0.180 |
Why?
|
| Health Surveys | 7 | 2016 | 4036 | 0.180 |
Why?
|
| Carbamazepine | 2 | 2011 | 229 | 0.180 |
Why?
|
| Statistics, Nonparametric | 7 | 2011 | 2887 | 0.180 |
Why?
|
| Evaluation Studies as Topic | 2 | 2009 | 1681 | 0.180 |
Why?
|
| Retrospective Studies | 38 | 2023 | 77460 | 0.180 |
Why?
|
| Vocabulary | 2 | 2017 | 169 | 0.180 |
Why?
|
| Medical History Taking | 4 | 2017 | 784 | 0.180 |
Why?
|
| Statistics as Topic | 9 | 2016 | 2373 | 0.180 |
Why?
|
| Play and Playthings | 1 | 2020 | 79 | 0.180 |
Why?
|
| Inositol | 2 | 2022 | 218 | 0.170 |
Why?
|
| Sleep | 2 | 2022 | 4622 | 0.170 |
Why?
|
| Parahippocampal Gyrus | 2 | 2014 | 116 | 0.170 |
Why?
|
| Point Mutation | 2 | 2005 | 1624 | 0.170 |
Why?
|
| Personality Development | 8 | 2003 | 245 | 0.170 |
Why?
|
| Environmental Pollutants | 1 | 2008 | 1179 | 0.170 |
Why?
|
| Age Distribution | 4 | 2011 | 2902 | 0.170 |
Why?
|
| Poison Control Centers | 1 | 2019 | 72 | 0.170 |
Why?
|
| Motor Skills Disorders | 2 | 2011 | 90 | 0.170 |
Why?
|
| Motor Activity | 6 | 2014 | 2715 | 0.170 |
Why?
|
| Chromosome Deletion | 3 | 2017 | 1401 | 0.170 |
Why?
|
| Internationality | 4 | 2016 | 1002 | 0.170 |
Why?
|
| Amygdala | 5 | 2022 | 1315 | 0.170 |
Why?
|
| Cerebrum | 1 | 2020 | 137 | 0.170 |
Why?
|
| Databases, Factual | 7 | 2024 | 7730 | 0.170 |
Why?
|
| Conditioning, Operant | 2 | 2010 | 313 | 0.170 |
Why?
|
| Psychotherapy, Group | 1 | 2022 | 406 | 0.160 |
Why?
|
| Corpus Striatum | 4 | 2017 | 1221 | 0.160 |
Why?
|
| Infant, Premature, Diseases | 1 | 2005 | 707 | 0.160 |
Why?
|
| Infant | 15 | 2019 | 35134 | 0.160 |
Why?
|
| Autoimmune Diseases | 2 | 2022 | 2134 | 0.160 |
Why?
|
| Teaching | 3 | 2005 | 1174 | 0.160 |
Why?
|
| Drug Substitution | 1 | 2021 | 281 | 0.160 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2019 | 187 | 0.160 |
Why?
|
| Calcineurin | 2 | 2011 | 226 | 0.160 |
Why?
|
| Models, Neurological | 5 | 2018 | 1775 | 0.160 |
Why?
|
| Time Perception | 2 | 2010 | 84 | 0.160 |
Why?
|
| Basal Ganglia | 3 | 2012 | 546 | 0.160 |
Why?
|
| Verbal Behavior | 5 | 2008 | 339 | 0.160 |
Why?
|
| Prognosis | 24 | 2017 | 29060 | 0.160 |
Why?
|
| Putamen | 2 | 2019 | 291 | 0.160 |
Why?
|
| Convergence, Ocular | 1 | 2018 | 24 | 0.160 |
Why?
|
| Morbidity | 5 | 2018 | 1768 | 0.160 |
Why?
|
| Valproic Acid | 2 | 2011 | 445 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 17 | 2017 | 8949 | 0.150 |
Why?
|
| Political Systems | 1 | 1997 | 23 | 0.150 |
Why?
|
| Universities | 2 | 2022 | 951 | 0.150 |
Why?
|
| War Crimes | 1 | 1997 | 22 | 0.150 |
Why?
|
| Psychology | 4 | 2024 | 356 | 0.150 |
Why?
|
| Reading | 4 | 2014 | 558 | 0.150 |
Why?
|
| Dopamine beta-Hydroxylase | 3 | 2008 | 75 | 0.150 |
Why?
|
| Socialization | 4 | 2006 | 87 | 0.150 |
Why?
|
| Personal Satisfaction | 2 | 2015 | 643 | 0.150 |
Why?
|
| Task Performance and Analysis | 6 | 2015 | 780 | 0.150 |
Why?
|
| Vocalization, Animal | 2 | 2016 | 87 | 0.150 |
Why?
|
| Nervous System Diseases | 2 | 2011 | 1622 | 0.150 |
Why?
|
| Receptors, Dopamine D1 | 4 | 2010 | 291 | 0.150 |
Why?
|
| Incidence | 13 | 2023 | 20952 | 0.150 |
Why?
|
| Seasons | 3 | 2008 | 1493 | 0.150 |
Why?
|
| Data Interpretation, Statistical | 6 | 2008 | 2716 | 0.150 |
Why?
|
| Infant, Low Birth Weight | 1 | 2002 | 850 | 0.150 |
Why?
|
| Cadherins | 3 | 2011 | 907 | 0.150 |
Why?
|
| Microsatellite Repeats | 8 | 2010 | 802 | 0.150 |
Why?
|
| Anger | 1 | 2019 | 402 | 0.150 |
Why?
|
| Drug Interactions | 3 | 2011 | 1460 | 0.150 |
Why?
|
| Professional Misconduct | 1 | 1997 | 73 | 0.150 |
Why?
|
| Memory | 8 | 2010 | 2174 | 0.150 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2017 | 162 | 0.140 |
Why?
|
| Human Experimentation | 1 | 1997 | 127 | 0.140 |
Why?
|
| Reminder Systems | 1 | 2020 | 371 | 0.140 |
Why?
|
| Neuronal Plasticity | 3 | 2016 | 1423 | 0.140 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 1707 | 0.140 |
Why?
|
| Pituitary-Adrenal System | 3 | 2017 | 553 | 0.140 |
Why?
|
| Administration, Oral | 3 | 2016 | 3914 | 0.140 |
Why?
|
| Twins, Dizygotic | 6 | 2012 | 236 | 0.140 |
Why?
|
| Autophagy | 2 | 2021 | 1297 | 0.140 |
Why?
|
| Chromosome Segregation | 2 | 2013 | 235 | 0.140 |
Why?
|
| Hypoglycemia | 1 | 2024 | 861 | 0.140 |
Why?
|
| Area Under Curve | 2 | 2016 | 1655 | 0.140 |
Why?
|
| Narcotic Antagonists | 2 | 2018 | 562 | 0.140 |
Why?
|
| Serial Learning | 2 | 2015 | 45 | 0.140 |
Why?
|
| Genetic Research | 1 | 1997 | 174 | 0.140 |
Why?
|
| Myosin Heavy Chains | 2 | 2008 | 414 | 0.140 |
Why?
|
| Receptors, Notch | 4 | 2012 | 739 | 0.140 |
Why?
|
| Risk Assessment | 16 | 2020 | 23336 | 0.140 |
Why?
|
| DNA Methylation | 4 | 2019 | 4285 | 0.140 |
Why?
|
| Human Rights | 2 | 1997 | 307 | 0.140 |
Why?
|
| Color Perception | 3 | 2015 | 213 | 0.140 |
Why?
|
| Gene Expression Regulation | 5 | 2018 | 12073 | 0.140 |
Why?
|
| Biological Psychiatry | 1 | 2015 | 25 | 0.140 |
Why?
|
| Resilience, Psychological | 1 | 2023 | 677 | 0.140 |
Why?
|
| Birth Rate | 1 | 2017 | 170 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 17 | 4 | 2012 | 437 | 0.140 |
Why?
|
| History, 20th Century | 5 | 2018 | 2740 | 0.130 |
Why?
|
| Uncertainty | 1 | 2021 | 735 | 0.130 |
Why?
|
| Maze Learning | 2 | 2016 | 478 | 0.130 |
Why?
|
| Molecular Epidemiology | 2 | 2011 | 468 | 0.130 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2017 | 703 | 0.130 |
Why?
|
| Outpatients | 5 | 2019 | 1487 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2019 | 2916 | 0.130 |
Why?
|
| Glutamic Acid | 2 | 2020 | 1169 | 0.130 |
Why?
|
| Concept Formation | 4 | 1998 | 158 | 0.130 |
Why?
|
| Random Allocation | 5 | 2017 | 2428 | 0.130 |
Why?
|
| 3' Untranslated Regions | 4 | 2012 | 513 | 0.130 |
Why?
|
| Marijuana Smoking | 1 | 2019 | 253 | 0.130 |
Why?
|
| Patient Selection | 5 | 2010 | 4216 | 0.130 |
Why?
|
| Blood Pressure | 2 | 2010 | 8551 | 0.130 |
Why?
|
| History, 21st Century | 4 | 2018 | 1534 | 0.130 |
Why?
|
| Neuroanatomy | 2 | 2017 | 66 | 0.130 |
Why?
|
| Valine | 2 | 2010 | 413 | 0.130 |
Why?
|
| Dibenzothiazepines | 2 | 2014 | 103 | 0.130 |
Why?
|
| Fetal Development | 1 | 2021 | 767 | 0.130 |
Why?
|
| Transdermal Patch | 1 | 2015 | 51 | 0.130 |
Why?
|
| Attitude to Health | 2 | 2008 | 2052 | 0.130 |
Why?
|
| Vesicular Transport Proteins | 1 | 2017 | 377 | 0.120 |
Why?
|
| Child Health Services | 2 | 2017 | 667 | 0.120 |
Why?
|
| Infant, Newborn | 9 | 2022 | 25628 | 0.120 |
Why?
|
| Glutamate Decarboxylase | 2 | 2009 | 245 | 0.120 |
Why?
|
| Microarray Analysis | 1 | 2017 | 767 | 0.120 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2016 | 302 | 0.120 |
Why?
|
| Hyperalgesia | 1 | 2018 | 502 | 0.120 |
Why?
|
| Methionine | 2 | 2010 | 590 | 0.120 |
Why?
|
| Psychomotor Agitation | 2 | 2015 | 293 | 0.120 |
Why?
|
| Delusions | 4 | 2009 | 300 | 0.120 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2013 | 1107 | 0.120 |
Why?
|
| Brain Chemistry | 3 | 2006 | 982 | 0.120 |
Why?
|
| Housing, Animal | 1 | 2014 | 48 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2007 | 798 | 0.120 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 551 | 0.120 |
Why?
|
| Homozygote | 4 | 2016 | 1787 | 0.120 |
Why?
|
| Genetic Fitness | 2 | 2016 | 121 | 0.120 |
Why?
|
| Disease Progression | 12 | 2014 | 13286 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 12 | 3 | 2012 | 462 | 0.120 |
Why?
|
| Calcium Channels, L-Type | 1 | 2015 | 240 | 0.120 |
Why?
|
| Workplace | 2 | 2012 | 836 | 0.120 |
Why?
|
| Receptors, Metabotropic Glutamate | 3 | 2011 | 211 | 0.120 |
Why?
|
| Communicable Diseases | 1 | 2022 | 880 | 0.120 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2016 | 449 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2013 | 2110 | 0.110 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2013 | 65 | 0.110 |
Why?
|
| Databases, Bibliographic | 1 | 2013 | 128 | 0.110 |
Why?
|
| Pyridoxine | 1 | 2013 | 102 | 0.110 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2013 | 212 | 0.110 |
Why?
|
| Student Dropouts | 1 | 2013 | 27 | 0.110 |
Why?
|
| Trinucleotide Repeats | 2 | 2005 | 261 | 0.110 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 1344 | 0.110 |
Why?
|
| Internal-External Control | 3 | 2010 | 363 | 0.110 |
Why?
|
| Ethics, Medical | 2 | 2001 | 792 | 0.110 |
Why?
|
| Ultrasonics | 1 | 2014 | 212 | 0.110 |
Why?
|
| F-Box Proteins | 1 | 2014 | 196 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 5 | 2008 | 5867 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2007 | 4232 | 0.110 |
Why?
|
| Central Nervous System Agents | 1 | 2013 | 72 | 0.110 |
Why?
|
| Pyramidal Tracts | 1 | 2015 | 256 | 0.110 |
Why?
|
| Epigenesis, Genetic | 5 | 2019 | 3646 | 0.110 |
Why?
|
| Exploratory Behavior | 1 | 2014 | 270 | 0.110 |
Why?
|
| Psychoneuroimmunology | 1 | 2012 | 13 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 1081 | 0.110 |
Why?
|
| Biomedical Research | 4 | 2011 | 3309 | 0.110 |
Why?
|
| Sexual Behavior | 3 | 2018 | 2055 | 0.110 |
Why?
|
| Mental Health Services | 1 | 2024 | 1644 | 0.110 |
Why?
|
| Lithium Compounds | 1 | 2014 | 225 | 0.110 |
Why?
|
| Docosahexaenoic Acids | 2 | 2016 | 875 | 0.110 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2012 | 19 | 0.110 |
Why?
|
| Prolactin | 4 | 1993 | 669 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2012 | 1862 | 0.100 |
Why?
|
| Clinical Protocols | 2 | 2014 | 1461 | 0.100 |
Why?
|
| Feasibility Studies | 2 | 2020 | 5077 | 0.100 |
Why?
|
| Cannabis | 1 | 2019 | 440 | 0.100 |
Why?
|
| Telomerase | 1 | 2017 | 730 | 0.100 |
Why?
|
| Receptors, Peptide | 2 | 2011 | 272 | 0.100 |
Why?
|
| Hypertension | 2 | 2018 | 8479 | 0.100 |
Why?
|
| Rats, Mutant Strains | 1 | 2011 | 70 | 0.100 |
Why?
|
| Neurosciences | 2 | 2020 | 348 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2015 | 3326 | 0.100 |
Why?
|
| Annexin A7 | 1 | 2011 | 3 | 0.100 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 658 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2012 | 6539 | 0.100 |
Why?
|
| Semaphorin-3A | 1 | 2011 | 39 | 0.100 |
Why?
|
| Causality | 4 | 2012 | 1275 | 0.100 |
Why?
|
| Models, Statistical | 9 | 2019 | 5101 | 0.100 |
Why?
|
| Physicians, Primary Care | 1 | 2018 | 592 | 0.100 |
Why?
|
| Nerve Growth Factors | 1 | 2014 | 574 | 0.100 |
Why?
|
| Volition | 4 | 1999 | 63 | 0.100 |
Why?
|
| Isoxazoles | 1 | 2013 | 216 | 0.100 |
Why?
|
| Drive | 1 | 2011 | 35 | 0.100 |
Why?
|
| Flushing | 1 | 2011 | 49 | 0.100 |
Why?
|
| Psychology, Social | 1 | 2011 | 51 | 0.100 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2015 | 582 | 0.100 |
Why?
|
| Carrier Proteins | 4 | 2011 | 5023 | 0.100 |
Why?
|
| Research | 2 | 2015 | 1999 | 0.100 |
Why?
|
| School Health Services | 1 | 2015 | 375 | 0.100 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2011 | 80 | 0.100 |
Why?
|
| Consensus | 1 | 2020 | 2960 | 0.100 |
Why?
|
| Confidence Intervals | 8 | 2010 | 2971 | 0.090 |
Why?
|
| 5' Untranslated Regions | 2 | 2008 | 249 | 0.090 |
Why?
|
| Antibodies, Antinuclear | 1 | 2012 | 326 | 0.090 |
Why?
|
| Reinforcement Schedule | 1 | 2010 | 129 | 0.090 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2010 | 90 | 0.090 |
Why?
|
| Hallucinations | 3 | 2009 | 360 | 0.090 |
Why?
|
| Depression, Postpartum | 1 | 2015 | 340 | 0.090 |
Why?
|
| Antigens, Bacterial | 4 | 1998 | 1172 | 0.090 |
Why?
|
| Canada | 2 | 2015 | 2065 | 0.090 |
Why?
|
| Niacin | 1 | 2011 | 116 | 0.090 |
Why?
|
| DNA Mutational Analysis | 5 | 2019 | 4185 | 0.090 |
Why?
|
| Early Diagnosis | 2 | 2013 | 1184 | 0.090 |
Why?
|
| Sialoglycoproteins | 1 | 2011 | 318 | 0.090 |
Why?
|
| Pain Measurement | 2 | 2018 | 3420 | 0.090 |
Why?
|
| Ambulatory Care | 8 | 2018 | 2708 | 0.090 |
Why?
|
| Shyness | 4 | 2004 | 21 | 0.090 |
Why?
|
| Nicotinic Agonists | 2 | 2010 | 271 | 0.090 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 2 | 1 | 2009 | 7 | 0.090 |
Why?
|
| Asperger Syndrome | 1 | 2010 | 63 | 0.090 |
Why?
|
| Ireland | 2 | 2015 | 161 | 0.090 |
Why?
|
| Psychopharmacology | 1 | 1992 | 143 | 0.090 |
Why?
|
| Protein Binding | 2 | 2013 | 9384 | 0.090 |
Why?
|
| Selenium-Binding Proteins | 1 | 2009 | 14 | 0.090 |
Why?
|
| Selection Bias | 3 | 2010 | 371 | 0.090 |
Why?
|
| Oxygen | 9 | 2017 | 4189 | 0.090 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2009 | 30 | 0.090 |
Why?
|
| Auditory Perceptual Disorders | 2 | 2008 | 36 | 0.090 |
Why?
|
| Postpartum Period | 2 | 2015 | 1086 | 0.090 |
Why?
|
| Interleukin-4 | 1 | 2013 | 1147 | 0.090 |
Why?
|
| Genetic Testing | 5 | 2011 | 3444 | 0.090 |
Why?
|
| Genetic Counseling | 3 | 2001 | 600 | 0.090 |
Why?
|
| Brain Diseases | 2 | 2018 | 1563 | 0.090 |
Why?
|
| Drinking Behavior | 1 | 2010 | 103 | 0.090 |
Why?
|
| CLOCK Proteins | 1 | 2009 | 88 | 0.090 |
Why?
|
| Language | 1 | 2019 | 1471 | 0.090 |
Why?
|
| Ethics, Research | 2 | 2008 | 191 | 0.090 |
Why?
|
| Immunoglobulin A | 3 | 1998 | 995 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 1416 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2024 | 3338 | 0.080 |
Why?
|
| Glucose | 3 | 2023 | 4398 | 0.080 |
Why?
|
| Clinical Trials, Phase IV as Topic | 1 | 2008 | 27 | 0.080 |
Why?
|
| Neuregulins | 1 | 2008 | 35 | 0.080 |
Why?
|
| Health Services | 1 | 2014 | 758 | 0.080 |
Why?
|
| Residence Characteristics | 2 | 2017 | 2050 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 2839 | 0.080 |
Why?
|
| Base Sequence | 4 | 2008 | 12797 | 0.080 |
Why?
|
| Health Status Indicators | 1 | 2014 | 970 | 0.080 |
Why?
|
| Central Nervous System Depressants | 1 | 2010 | 167 | 0.080 |
Why?
|
| Cocaine | 3 | 2014 | 1007 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 906 | 0.080 |
Why?
|
| Behavior, Animal | 4 | 2010 | 1881 | 0.080 |
Why?
|
| Aged, 80 and over | 10 | 2021 | 57776 | 0.080 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 2000 | 254 | 0.080 |
Why?
|
| Comprehension | 1 | 2014 | 610 | 0.080 |
Why?
|
| PubMed | 1 | 2009 | 123 | 0.080 |
Why?
|
| Perceptual Disorders | 2 | 2008 | 196 | 0.080 |
Why?
|
| Fetal Diseases | 1 | 2014 | 903 | 0.080 |
Why?
|
| Guidelines as Topic | 2 | 2006 | 1405 | 0.080 |
Why?
|
| Semantics | 2 | 2003 | 585 | 0.080 |
Why?
|
| Search Engine | 1 | 2009 | 144 | 0.080 |
Why?
|
| Kinesthesis | 1 | 2008 | 23 | 0.080 |
Why?
|
| Metabolomics | 1 | 2017 | 1485 | 0.080 |
Why?
|
| New York | 3 | 2014 | 886 | 0.080 |
Why?
|
| Brazil | 3 | 2024 | 1270 | 0.080 |
Why?
|
| Dreams | 1 | 2009 | 147 | 0.080 |
Why?
|
| Animal Experimentation | 1 | 2008 | 45 | 0.080 |
Why?
|
| Myosin Type V | 1 | 2008 | 34 | 0.080 |
Why?
|
| Torture | 1 | 1988 | 53 | 0.080 |
Why?
|
| Prenatal Diagnosis | 1 | 2015 | 1236 | 0.080 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2016 | 1695 | 0.080 |
Why?
|
| GTP-Binding Proteins | 2 | 2013 | 970 | 0.080 |
Why?
|
| Molecular Motor Proteins | 1 | 2008 | 107 | 0.080 |
Why?
|
| Twins, Monozygotic | 5 | 2012 | 458 | 0.080 |
Why?
|
| Occupations | 1 | 2010 | 517 | 0.080 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 328 | 0.080 |
Why?
|
| Accidents, Traffic | 2 | 2020 | 819 | 0.080 |
Why?
|
| Gene Deletion | 2 | 2013 | 2751 | 0.080 |
Why?
|
| Borderline Personality Disorder | 1 | 2015 | 736 | 0.080 |
Why?
|
| Child Abuse | 1 | 2016 | 1030 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2012 | 721 | 0.080 |
Why?
|
| Lung Diseases | 2 | 1997 | 1887 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2020 | 4208 | 0.080 |
Why?
|
| Neuropsychology | 1 | 2008 | 110 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 4 | 2008 | 7282 | 0.070 |
Why?
|
| Remission, Spontaneous | 2 | 2015 | 382 | 0.070 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 4153 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2013 | 3759 | 0.070 |
Why?
|
| California | 1 | 2011 | 1402 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2008 | 326 | 0.070 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 822 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 1152 | 0.070 |
Why?
|
| Lung Diseases, Obstructive | 2 | 2001 | 316 | 0.070 |
Why?
|
| Logic | 1 | 2006 | 39 | 0.070 |
Why?
|
| Attitude | 1 | 2012 | 776 | 0.070 |
Why?
|
| Periodicals as Topic | 2 | 2008 | 1431 | 0.070 |
Why?
|
| Community Mental Health Services | 1 | 2010 | 386 | 0.070 |
Why?
|
| DNA Primers | 2 | 2008 | 2891 | 0.070 |
Why?
|
| Norway | 3 | 2014 | 448 | 0.070 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2008 | 323 | 0.070 |
Why?
|
| Self Medication | 1 | 2007 | 117 | 0.070 |
Why?
|
| Receptor, Notch2 | 1 | 2006 | 89 | 0.070 |
Why?
|
| Birth Order | 1 | 2006 | 95 | 0.070 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 1364 | 0.070 |
Why?
|
| Survival Analysis | 4 | 2009 | 10252 | 0.070 |
Why?
|
| RGS Proteins | 1 | 2006 | 77 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2018 | 11726 | 0.070 |
Why?
|
| Social Control, Formal | 1 | 2006 | 110 | 0.070 |
Why?
|
| Galantamine | 1 | 2006 | 32 | 0.070 |
Why?
|
| Information Services | 1 | 2007 | 244 | 0.070 |
Why?
|
| Apolipoproteins | 1 | 2008 | 317 | 0.070 |
Why?
|
| Receptors, Opioid, mu | 1 | 2007 | 182 | 0.070 |
Why?
|
| CpG Islands | 4 | 2019 | 1170 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2011 | 1222 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2010 | 4042 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2008 | 3611 | 0.070 |
Why?
|
| Dominance, Cerebral | 5 | 2012 | 635 | 0.070 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2010 | 841 | 0.070 |
Why?
|
| Denmark | 2 | 2019 | 738 | 0.070 |
Why?
|
| Touch | 1 | 2008 | 306 | 0.070 |
Why?
|
| Bayes Theorem | 3 | 2020 | 2307 | 0.070 |
Why?
|
| Hospitals, General | 2 | 2015 | 749 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2012 | 2649 | 0.070 |
Why?
|
| Membrane Proteins | 3 | 2022 | 7882 | 0.070 |
Why?
|
| Work | 1 | 2006 | 191 | 0.060 |
Why?
|
| Apoptosis | 1 | 2021 | 9724 | 0.060 |
Why?
|
| Terrorism | 1 | 2008 | 211 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2013 | 10183 | 0.060 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 1997 | 810 | 0.060 |
Why?
|
| Developmental Disabilities | 2 | 2010 | 1456 | 0.060 |
Why?
|
| Models, Theoretical | 3 | 2019 | 3589 | 0.060 |
Why?
|
| Mental Health Associations | 1 | 2004 | 2 | 0.060 |
Why?
|
| Chromosomes, Human, X | 1 | 2006 | 296 | 0.060 |
Why?
|
| Longevity | 2 | 2023 | 1071 | 0.060 |
Why?
|
| Perception | 2 | 2010 | 1198 | 0.060 |
Why?
|
| Databases, Nucleic Acid | 2 | 2016 | 211 | 0.060 |
Why?
|
| Mental Health | 3 | 2020 | 3010 | 0.060 |
Why?
|
| Heterozygote | 4 | 2017 | 2804 | 0.060 |
Why?
|
| Nucleus Accumbens | 2 | 2019 | 366 | 0.060 |
Why?
|
| Receptors, Glutamate | 1 | 2005 | 232 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2008 | 622 | 0.060 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2006 | 238 | 0.060 |
Why?
|
| Biological Availability | 3 | 2008 | 397 | 0.060 |
Why?
|
| Clomipramine | 1 | 2003 | 54 | 0.060 |
Why?
|
| Pregnancy Outcome | 1 | 2014 | 2795 | 0.060 |
Why?
|
| Lipoproteins, HDL | 1 | 2008 | 638 | 0.060 |
Why?
|
| Parturition | 1 | 2008 | 441 | 0.060 |
Why?
|
| Information Theory | 1 | 1984 | 51 | 0.060 |
Why?
|
| Mice | 8 | 2022 | 81201 | 0.060 |
Why?
|
| Journalism, Medical | 1 | 2004 | 74 | 0.060 |
Why?
|
| Aptitude | 2 | 2012 | 45 | 0.060 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2003 | 49 | 0.060 |
Why?
|
| International Agencies | 1 | 2004 | 240 | 0.060 |
Why?
|
| Alcohol Drinking | 2 | 2010 | 3966 | 0.060 |
Why?
|
| Cost of Illness | 2 | 2011 | 1860 | 0.060 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2005 | 369 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2011 | 1660 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2012 | 2441 | 0.060 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2005 | 266 | 0.060 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2004 | 769 | 0.060 |
Why?
|
| Coitus | 1 | 2004 | 133 | 0.060 |
Why?
|
| Ethanol | 1 | 2010 | 1342 | 0.060 |
Why?
|
| Arabidopsis Proteins | 2 | 2017 | 262 | 0.060 |
Why?
|
| Time | 1 | 2005 | 542 | 0.060 |
Why?
|
| Dissent and Disputes | 1 | 2004 | 141 | 0.060 |
Why?
|
| Adaptation, Psychological | 2 | 2013 | 2575 | 0.060 |
Why?
|
| Ganglionic Stimulants | 1 | 2002 | 19 | 0.060 |
Why?
|
| Neurotic Disorders | 3 | 1997 | 79 | 0.060 |
Why?
|
| Efficiency | 1 | 2006 | 462 | 0.060 |
Why?
|
| Research Personnel | 1 | 2008 | 573 | 0.060 |
Why?
|
| Editorial Policies | 1 | 2008 | 451 | 0.060 |
Why?
|
| Platelet Activating Factor | 2 | 2000 | 149 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 1997 | 768 | 0.060 |
Why?
|
| Epilepsy | 2 | 2010 | 3310 | 0.060 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 935 | 0.050 |
Why?
|
| Conflict of Interest | 1 | 2008 | 544 | 0.050 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2003 | 67 | 0.050 |
Why?
|
| Life Style | 1 | 2014 | 3835 | 0.050 |
Why?
|
| Smell | 2 | 1997 | 244 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 4 | 1998 | 780 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2014 | 1796 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2013 | 3020 | 0.050 |
Why?
|
| Health Behavior | 1 | 2014 | 2635 | 0.050 |
Why?
|
| Enzymes | 1 | 2004 | 266 | 0.050 |
Why?
|
| Commitment of Mentally Ill | 1 | 1982 | 94 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 3677 | 0.050 |
Why?
|
| Movement Disorders | 1 | 2006 | 446 | 0.050 |
Why?
|
| Syndrome | 2 | 1999 | 3252 | 0.050 |
Why?
|
| Pandemics | 4 | 2024 | 8385 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 2005 | 1144 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2006 | 737 | 0.050 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2002 | 158 | 0.050 |
Why?
|
| Sampling Studies | 4 | 2010 | 623 | 0.050 |
Why?
|
| Phonetics | 1 | 2003 | 206 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 1178 | 0.050 |
Why?
|
| Cues | 2 | 2012 | 875 | 0.050 |
Why?
|
| Ethics | 1 | 2001 | 94 | 0.050 |
Why?
|
| Marriage | 4 | 2001 | 339 | 0.050 |
Why?
|
| Least-Squares Analysis | 1 | 2002 | 379 | 0.050 |
Why?
|
| Pulmonary Fibrosis | 2 | 1997 | 530 | 0.050 |
Why?
|
| Social Desirability | 2 | 2001 | 47 | 0.050 |
Why?
|
| Signal Transduction | 5 | 2020 | 23404 | 0.050 |
Why?
|
| Hypothalamus | 1 | 2006 | 1063 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2013 | 2943 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2005 | 850 | 0.050 |
Why?
|
| Sensory Receptor Cells | 1 | 2005 | 493 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2003 | 563 | 0.050 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2021 | 262 | 0.050 |
Why?
|
| Obstetric Labor, Premature | 1 | 2002 | 279 | 0.050 |
Why?
|
| Phosphates | 1 | 2023 | 785 | 0.050 |
Why?
|
| Airway Resistance | 2 | 2000 | 404 | 0.050 |
Why?
|
| Glycolysis | 1 | 2004 | 829 | 0.040 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2019 | 34 | 0.040 |
Why?
|
| Psychological Theory | 1 | 2001 | 168 | 0.040 |
Why?
|
| Nitric Oxide | 2 | 2000 | 2132 | 0.040 |
Why?
|
| History, Ancient | 1 | 2020 | 212 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2008 | 1988 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 4 | 3 | 2008 | 374 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 2003 | 435 | 0.040 |
Why?
|
| Limbic System | 3 | 2006 | 426 | 0.040 |
Why?
|
| Sexual Partners | 1 | 2004 | 729 | 0.040 |
Why?
|
| Nonverbal Communication | 1 | 1999 | 63 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2005 | 1073 | 0.040 |
Why?
|
| Radioligand Assay | 2 | 2010 | 374 | 0.040 |
Why?
|
| Cocaine-Related Disorders | 1 | 2003 | 460 | 0.040 |
Why?
|
| Dopamine Agents | 1 | 2000 | 189 | 0.040 |
Why?
|
| Chronic Disease | 8 | 2004 | 9145 | 0.040 |
Why?
|
| Systems Analysis | 1 | 2020 | 172 | 0.040 |
Why?
|
| Medical Records | 3 | 2000 | 1413 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2011 | 13035 | 0.040 |
Why?
|
| Endothelin-1 | 1 | 2001 | 314 | 0.040 |
Why?
|
| Rest | 2 | 2017 | 901 | 0.040 |
Why?
|
| Vietnam | 1 | 1999 | 408 | 0.040 |
Why?
|
| International Classification of Diseases | 1 | 2004 | 867 | 0.040 |
Why?
|
| Paternal Age | 1 | 2019 | 84 | 0.040 |
Why?
|
| Occipital Lobe | 2 | 2017 | 379 | 0.040 |
Why?
|
| Motor Skills | 2 | 2010 | 522 | 0.040 |
Why?
|
| Family Therapy | 1 | 2020 | 207 | 0.040 |
Why?
|
| Privacy | 1 | 2001 | 238 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2003 | 764 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2014 | 1892 | 0.040 |
Why?
|
| Drug Dosage Calculations | 1 | 2019 | 114 | 0.040 |
Why?
|
| Dyskinesia, Drug-Induced | 2 | 1989 | 163 | 0.040 |
Why?
|
| Germany | 2 | 2011 | 862 | 0.040 |
Why?
|
| Computational Biology | 3 | 2021 | 3519 | 0.040 |
Why?
|
| Nasal Obstruction | 1 | 2000 | 151 | 0.040 |
Why?
|
| Vision, Binocular | 1 | 2020 | 213 | 0.040 |
Why?
|
| Women's Health | 1 | 2008 | 2034 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2006 | 1541 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 2 | 2000 | 915 | 0.040 |
Why?
|
| Eugenics | 1 | 1997 | 15 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2011 | 3229 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2002 | 875 | 0.040 |
Why?
|
| Intramolecular Lyases | 1 | 2017 | 11 | 0.040 |
Why?
|
| Sertraline | 1 | 1999 | 206 | 0.040 |
Why?
|
| Schizophrenic Language | 1 | 1997 | 69 | 0.040 |
Why?
|
| Adolescent Health Services | 1 | 2000 | 215 | 0.040 |
Why?
|
| Hospitalization | 3 | 2022 | 10259 | 0.040 |
Why?
|
| Therapeutic Equivalency | 1 | 2017 | 141 | 0.040 |
Why?
|
| Australia | 1 | 2020 | 1167 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 6234 | 0.040 |
Why?
|
| Behavioral Symptoms | 1 | 1999 | 175 | 0.040 |
Why?
|
| Codes of Ethics | 1 | 1997 | 62 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 3395 | 0.040 |
Why?
|
| Psychotherapy | 2 | 2018 | 1642 | 0.040 |
Why?
|
| Sample Size | 1 | 2021 | 845 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2020 | 779 | 0.040 |
Why?
|
| Computers | 1 | 2020 | 612 | 0.040 |
Why?
|
| Data Collection | 5 | 2010 | 3339 | 0.040 |
Why?
|
| Preventive Health Services | 1 | 2002 | 575 | 0.040 |
Why?
|
| Bariatric Surgery | 1 | 2007 | 952 | 0.040 |
Why?
|
| Community Health Services | 1 | 2002 | 650 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 2504 | 0.040 |
Why?
|
| Veterans | 2 | 2001 | 2519 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2023 | 1683 | 0.040 |
Why?
|
| National Socialism | 1 | 1997 | 53 | 0.040 |
Why?
|
| Research Report | 1 | 2020 | 355 | 0.040 |
Why?
|
| Panic | 3 | 1991 | 106 | 0.040 |
Why?
|
| Education, Special | 2 | 1995 | 87 | 0.040 |
Why?
|
| Parenting | 2 | 2015 | 679 | 0.040 |
Why?
|
| Sociometric Techniques | 1 | 1996 | 10 | 0.040 |
Why?
|
| Phospholipases A | 1 | 1997 | 216 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 896 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 1438 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15160 | 0.040 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 182 | 0.040 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2018 | 230 | 0.040 |
Why?
|
| Awareness | 1 | 2021 | 640 | 0.040 |
Why?
|
| Finland | 1 | 2017 | 602 | 0.030 |
Why?
|
| Space Perception | 2 | 2011 | 475 | 0.030 |
Why?
|
| Fluphenazine | 3 | 1991 | 36 | 0.030 |
Why?
|
| Chromosome Aberrations | 2 | 2010 | 1813 | 0.030 |
Why?
|
| Drug Tolerance | 1 | 2018 | 376 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2020 | 627 | 0.030 |
Why?
|
| Homosexuality, Male | 1 | 2004 | 1240 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2007 | 1213 | 0.030 |
Why?
|
| Paranoid Personality Disorder | 1 | 1995 | 8 | 0.030 |
Why?
|
| Visual Perception | 3 | 2011 | 1420 | 0.030 |
Why?
|
| Social Perception | 1 | 1999 | 425 | 0.030 |
Why?
|
| Politics | 1 | 1982 | 791 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2004 | 1099 | 0.030 |
Why?
|
| Immunoglobulin G | 3 | 1998 | 4561 | 0.030 |
Why?
|
| Enuresis | 1 | 1995 | 47 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 5856 | 0.030 |
Why?
|
| Multigene Family | 1 | 1999 | 1102 | 0.030 |
Why?
|
| Urban Population | 2 | 2018 | 2022 | 0.030 |
Why?
|
| False Positive Reactions | 2 | 1995 | 980 | 0.030 |
Why?
|
| Weight Loss | 1 | 2007 | 2625 | 0.030 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 1995 | 43 | 0.030 |
Why?
|
| Dwarfism | 1 | 1996 | 146 | 0.030 |
Why?
|
| Health Promotion | 1 | 2008 | 2205 | 0.030 |
Why?
|
| Neurotransmitter Agents | 2 | 2011 | 647 | 0.030 |
Why?
|
| History, 19th Century | 1 | 2018 | 720 | 0.030 |
Why?
|
| X Chromosome | 2 | 1990 | 814 | 0.030 |
Why?
|
| Diagnostic Services | 1 | 2014 | 34 | 0.030 |
Why?
|
| Thiazoles | 1 | 2022 | 1483 | 0.030 |
Why?
|
| Pain Threshold | 1 | 2018 | 584 | 0.030 |
Why?
|
| Neostriatum | 1 | 2016 | 250 | 0.030 |
Why?
|
| Endothelium | 1 | 1997 | 778 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 209 | 0.030 |
Why?
|
| Models, Animal | 1 | 2001 | 2173 | 0.030 |
Why?
|
| Insulin | 1 | 2009 | 6582 | 0.030 |
Why?
|
| Multilevel Analysis | 1 | 2014 | 142 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2006 | 504 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2008 | 3841 | 0.030 |
Why?
|
| Marital Status | 1 | 1995 | 437 | 0.030 |
Why?
|
| Schizophrenia, Paranoid | 1 | 1994 | 104 | 0.030 |
Why?
|
| Globus Pallidus | 1 | 2015 | 253 | 0.030 |
Why?
|
| Boston | 4 | 2007 | 9312 | 0.030 |
Why?
|
| Parietal Lobe | 3 | 2006 | 838 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 2 | 2008 | 380 | 0.030 |
Why?
|
| Disabled Persons | 2 | 2001 | 1212 | 0.030 |
Why?
|
| Life Tables | 1 | 1994 | 370 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2003 | 2566 | 0.030 |
Why?
|
| Tuberculosis | 2 | 1998 | 1912 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2016 | 811 | 0.030 |
Why?
|
| Intramolecular Transferases | 1 | 2012 | 15 | 0.030 |
Why?
|
| Phencyclidine | 2 | 2007 | 61 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2012 | 47 | 0.030 |
Why?
|
| Protective Agents | 1 | 2014 | 156 | 0.030 |
Why?
|
| Prejudice | 1 | 1997 | 570 | 0.030 |
Why?
|
| Oncogene Proteins | 2 | 2008 | 749 | 0.030 |
Why?
|
| Proteome | 1 | 2003 | 1798 | 0.030 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2014 | 282 | 0.030 |
Why?
|
| Physical Chromosome Mapping | 1 | 2013 | 183 | 0.030 |
Why?
|
| Facial Expression | 2 | 2011 | 508 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2012 | 124 | 0.030 |
Why?
|
| Brain Damage, Chronic | 1 | 1993 | 265 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1995 | 514 | 0.030 |
Why?
|
| Pain | 1 | 2008 | 4988 | 0.030 |
Why?
|
| Dietary Sucrose | 1 | 2014 | 246 | 0.030 |
Why?
|
| Aptitude Tests | 1 | 2012 | 21 | 0.030 |
Why?
|
| Proteins | 1 | 2007 | 6100 | 0.030 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1995 | 525 | 0.030 |
Why?
|
| Hemodynamics | 2 | 2001 | 4196 | 0.030 |
Why?
|
| Saliva | 1 | 1996 | 809 | 0.030 |
Why?
|
| Doxorubicin | 1 | 1999 | 2234 | 0.030 |
Why?
|
| Feedback, Psychological | 1 | 2012 | 97 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2002 | 2047 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 2002 | 133 | 0.030 |
Why?
|
| Eye Movements | 1 | 1995 | 507 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 1988 | 0.030 |
Why?
|
| Community Health Planning | 1 | 2012 | 165 | 0.030 |
Why?
|
| Pharmacokinetics | 1 | 1992 | 88 | 0.030 |
Why?
|
| Anticipation, Psychological | 1 | 2012 | 87 | 0.030 |
Why?
|
| Stroop Test | 1 | 2011 | 62 | 0.030 |
Why?
|
| Piperazines | 1 | 2022 | 2488 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2020 | 1246 | 0.020 |
Why?
|
| Alcohol-Related Disorders | 2 | 2008 | 234 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2012 | 297 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2020 | 1939 | 0.020 |
Why?
|
| Actigraphy | 1 | 2015 | 488 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2016 | 914 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 1984 | 5388 | 0.020 |
Why?
|
| International Cooperation | 2 | 2007 | 1420 | 0.020 |
Why?
|
| Anticonvulsants | 2 | 2011 | 1916 | 0.020 |
Why?
|
| Lithium Carbonate | 1 | 2011 | 184 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 3508 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2015 | 908 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1998 | 3873 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 9647 | 0.020 |
Why?
|
| Litter Size | 1 | 2010 | 54 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2020 | 2938 | 0.020 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1990 | 114 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2016 | 1077 | 0.020 |
Why?
|
| Internet | 1 | 2022 | 3056 | 0.020 |
Why?
|
| Sequence Deletion | 2 | 2005 | 1525 | 0.020 |
Why?
|
| Radioimmunoassay | 3 | 1997 | 919 | 0.020 |
Why?
|
| Publishing | 1 | 1997 | 833 | 0.020 |
Why?
|
| Brain Stem | 1 | 2015 | 846 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2009 | 45 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2018 | 1004 | 0.020 |
Why?
|
| Social Support | 2 | 2011 | 2118 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2009 | 52 | 0.020 |
Why?
|
| Lorazepam | 1 | 1990 | 145 | 0.020 |
Why?
|
| Skin Tests | 1 | 2011 | 613 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1990 | 417 | 0.020 |
Why?
|
| Necrosis | 1 | 2013 | 1643 | 0.020 |
Why?
|
| Academic Medical Centers | 2 | 2013 | 2760 | 0.020 |
Why?
|
| Haloperidol | 2 | 1989 | 397 | 0.020 |
Why?
|
| Thinking | 2 | 2007 | 318 | 0.020 |
Why?
|
| Africa | 1 | 2011 | 672 | 0.020 |
Why?
|
| Sensory Gating | 1 | 2008 | 47 | 0.020 |
Why?
|
| Public Health | 1 | 2022 | 2602 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2016 | 1210 | 0.020 |
Why?
|
| Drinking | 1 | 2010 | 197 | 0.020 |
Why?
|
| Animal Rights | 1 | 2008 | 10 | 0.020 |
Why?
|
| Learning | 2 | 2014 | 1711 | 0.020 |
Why?
|
| Virus Diseases | 1 | 1995 | 711 | 0.020 |
Why?
|
| Spain | 1 | 2010 | 465 | 0.020 |
Why?
|
| Observation | 1 | 2010 | 312 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2012 | 2031 | 0.020 |
Why?
|
| Apraxias | 1 | 2009 | 64 | 0.020 |
Why?
|
| Access to Information | 1 | 2011 | 320 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2008 | 12207 | 0.020 |
Why?
|
| Child, Gifted | 1 | 2007 | 7 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2013 | 1958 | 0.020 |
Why?
|
| Synaptotagmin I | 1 | 2008 | 36 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2008 | 322 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 1994 | 1470 | 0.020 |
Why?
|
| Movement | 1 | 2015 | 1471 | 0.020 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2009 | 198 | 0.020 |
Why?
|
| Smoking Cessation | 3 | 2008 | 2071 | 0.020 |
Why?
|
| Fear | 2 | 2008 | 1440 | 0.020 |
Why?
|
| Dysthymic Disorder | 2 | 1998 | 74 | 0.020 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2008 | 110 | 0.020 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2007 | 61 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 1995 | 808 | 0.020 |
Why?
|
| Chromosomes | 1 | 2010 | 596 | 0.020 |
Why?
|
| Communication | 2 | 2011 | 3750 | 0.020 |
Why?
|
| Crime | 1 | 2008 | 215 | 0.020 |
Why?
|
| Language Development Disorders | 1 | 2008 | 196 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 1903 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 1865 | 0.020 |
Why?
|
| Self Concept | 1 | 2012 | 1025 | 0.020 |
Why?
|
| Divorce | 1 | 2006 | 79 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2010 | 1794 | 0.020 |
Why?
|
| Genetics, Behavioral | 1 | 2005 | 53 | 0.020 |
Why?
|
| Primates | 1 | 2008 | 545 | 0.020 |
Why?
|
| Clonidine | 1 | 2006 | 164 | 0.020 |
Why?
|
| Kidney | 1 | 2001 | 7184 | 0.020 |
Why?
|
| Remission Induction | 2 | 2004 | 2385 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2012 | 1431 | 0.020 |
Why?
|
| Phosphofructokinase-1 | 1 | 2004 | 51 | 0.020 |
Why?
|
| Phosphofructokinase-2 | 1 | 2004 | 32 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2005 | 467 | 0.020 |
Why?
|
| Hand | 1 | 2010 | 884 | 0.020 |
Why?
|
| Unemployment | 1 | 2006 | 214 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 2726 | 0.020 |
Why?
|
| Serine | 1 | 2008 | 826 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 1997 | 2375 | 0.010 |
Why?
|
| Hexokinase | 1 | 2004 | 124 | 0.010 |
Why?
|
| Models, Organizational | 1 | 2007 | 574 | 0.010 |
Why?
|
| Craniocerebral Trauma | 1 | 1988 | 482 | 0.010 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2003 | 45 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 2006 | 420 | 0.010 |
Why?
|
| Clozapine | 1 | 2007 | 498 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 288 | 0.010 |
Why?
|
| Drug Design | 1 | 2009 | 1076 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2007 | 959 | 0.010 |
Why?
|
| Genetic Load | 1 | 2003 | 15 | 0.010 |
Why?
|
| Cysteine | 1 | 2008 | 873 | 0.010 |
Why?
|
| USSR | 1 | 1982 | 21 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 1989 | 1019 | 0.010 |
Why?
|
| Ventricular Function, Right | 1 | 2007 | 591 | 0.010 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2002 | 30 | 0.010 |
Why?
|
| Myelin Sheath | 1 | 2007 | 652 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1999 | 4253 | 0.010 |
Why?
|
| Biometry | 1 | 2006 | 558 | 0.010 |
Why?
|
| Polysomnography | 1 | 2009 | 1776 | 0.010 |
Why?
|
| Geography | 1 | 2005 | 669 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2013 | 5974 | 0.010 |
Why?
|
| Pyruvate Kinase | 1 | 2004 | 189 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2010 | 1828 | 0.010 |
Why?
|
| Long-Term Care | 1 | 2006 | 607 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2005 | 655 | 0.010 |
Why?
|
| Radiography | 2 | 2008 | 7023 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 1793 | 0.010 |
Why?
|
| Menstruation | 1 | 2003 | 302 | 0.010 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2007 | 581 | 0.010 |
Why?
|
| Asia | 1 | 2003 | 609 | 0.010 |
Why?
|
| Sleep Deprivation | 1 | 2008 | 832 | 0.010 |
Why?
|
| Nasal Provocation Tests | 1 | 2000 | 9 | 0.010 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2001 | 109 | 0.010 |
Why?
|
| Enkephalins | 1 | 2001 | 154 | 0.010 |
Why?
|
| Refugees | 1 | 1988 | 511 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2007 | 1121 | 0.010 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2001 | 124 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2016 | 14561 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2013 | 2304 | 0.010 |
Why?
|
| Bradykinin | 1 | 2000 | 214 | 0.010 |
Why?
|
| Infant Behavior | 1 | 2001 | 156 | 0.010 |
Why?
|
| Social Problems | 1 | 2000 | 112 | 0.010 |
Why?
|
| Puberty | 1 | 2003 | 490 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 5882 | 0.010 |
Why?
|
| Benzhydryl Compounds | 1 | 2006 | 845 | 0.010 |
Why?
|
| Cross-Cultural Comparison | 1 | 2003 | 651 | 0.010 |
Why?
|
| Psoriasis | 1 | 2007 | 902 | 0.010 |
Why?
|
| Hypercapnia | 1 | 2001 | 260 | 0.010 |
Why?
|
| Japan | 1 | 2003 | 1360 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1999 | 234 | 0.010 |
Why?
|
| Physician's Role | 1 | 2006 | 943 | 0.010 |
Why?
|
| Signal Detection, Psychological | 1 | 1998 | 85 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2006 | 1504 | 0.010 |
Why?
|
| Acute Disease | 2 | 2001 | 7147 | 0.010 |
Why?
|
| Decision Making | 1 | 2012 | 3888 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 2624 | 0.010 |
Why?
|
| Hospitals, Veterans | 1 | 2000 | 404 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 1999 | 245 | 0.010 |
Why?
|
| Bronchoconstrictor Agents | 1 | 1997 | 77 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4751 | 0.010 |
Why?
|
| State Government | 1 | 2000 | 372 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 1997 | 203 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 1997 | 233 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1998 | 367 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1997 | 191 | 0.010 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 1997 | 127 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2001 | 1154 | 0.010 |
Why?
|
| Breath Tests | 1 | 1997 | 280 | 0.010 |
Why?
|
| Criminal Psychology | 1 | 1995 | 17 | 0.010 |
Why?
|
| Serologic Tests | 1 | 1998 | 374 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2002 | 1530 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1999 | 13693 | 0.010 |
Why?
|
| Specialization | 1 | 2000 | 776 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 9735 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 19233 | 0.010 |
Why?
|
| Cerebral Ventricles | 1 | 1997 | 544 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 2749 | 0.010 |
Why?
|
| Receptors, Androgen | 1 | 2001 | 1058 | 0.010 |
Why?
|
| Inflammation | 1 | 2014 | 10637 | 0.010 |
Why?
|
| Informed Consent | 1 | 2001 | 995 | 0.010 |
Why?
|
| Atrophy | 1 | 1999 | 1584 | 0.010 |
Why?
|
| Tuberculin | 1 | 1994 | 66 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 16000 | 0.010 |
Why?
|
| Confidentiality | 1 | 1998 | 612 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 4805 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1997 | 1799 | 0.010 |
Why?
|
| Dichotic Listening Tests | 1 | 1993 | 22 | 0.010 |
Why?
|
| Hallucinogens | 1 | 1996 | 180 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2006 | 2789 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2001 | 2190 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2001 | 2166 | 0.010 |
Why?
|
| Juvenile Delinquency | 1 | 1993 | 125 | 0.010 |
Why?
|
| Marijuana Abuse | 1 | 1996 | 403 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 18111 | 0.010 |
Why?
|
| Medicine | 1 | 2000 | 946 | 0.010 |
Why?
|
| Italy | 1 | 1994 | 832 | 0.010 |
Why?
|
| Creatinine | 1 | 1997 | 1919 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2003 | 2400 | 0.010 |
Why?
|
| Prednisone | 1 | 1995 | 1574 | 0.010 |
Why?
|
| Social Isolation | 1 | 1993 | 365 | 0.010 |
Why?
|
| Somatoform Disorders | 1 | 1993 | 423 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1991 | 552 | 0.010 |
Why?
|
| Thioridazine | 1 | 1989 | 33 | 0.010 |
Why?
|
| Chlorpromazine | 1 | 1989 | 111 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 21833 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1993 | 1617 | 0.010 |
Why?
|
| Lung | 2 | 1997 | 9857 | 0.010 |
Why?
|
| Hypnotics and Sedatives | 1 | 1996 | 1162 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 16690 | 0.000 |
Why?
|
| Heart Rate | 1 | 1999 | 4092 | 0.000 |
Why?
|
| Military Personnel | 1 | 1996 | 1133 | 0.000 |
Why?
|
| Electrocardiography | 1 | 2001 | 6442 | 0.000 |
Why?
|
| Testosterone | 1 | 1995 | 2419 | 0.000 |
Why?
|
| Patient Care Team | 1 | 1996 | 2531 | 0.000 |
Why?
|
| Monte Carlo Method | 1 | 1989 | 1254 | 0.000 |
Why?
|
| Mortality | 1 | 1993 | 2864 | 0.000 |
Why?
|